Pfizer's vaccine to protect newborns from respiratory syncytial virus, or RSV, by vaccinating their moms late in pregnancy cuts the risk that infants will need to see a doctor or be admitted to the hospital with a moderate to severe infection before 6 months of age, according to a new analysis by government regulators.

Topics:  rsv   pfizer's   vaccine   severe   newborns   risk   
BING NEWS:
  • Understanding Parental Decision-Making for Nirsevimab in RSV Prevention
    The following is a summary of “Parent Perspectives on Nirsevimab for Their Newborn,” published in the November 2024 issue of Pediatrics by Hinderstein et al. In 2023, the U.S. Food and Drug ...
    12/2/2024 - 12:14 am | View Link
  • Maternal RSV Vaccination’s Impact on Infant Health and Cost-Effectiveness
    Effectiveness of Maternal Vaccination to Prevent Respiratory Syncytial Virus Illness,” published in the November 2024 issue of Pediatrics by Hutton et al. Among infants in the United States, ...
    11/26/2024 - 9:53 pm | View Link
  • RSV Vaccine: What You Need to Know
    Learn about this vaccine that protects against a common seasonal virus that can sometimes cause severe disease, with info on safety and side effects.
    11/26/2024 - 5:50 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Health News